A variety of particles forming microencapsulated thermochromic materials are provided. The particles can include a thermochromic core and a metal oxide shell encapsulating the thermochromic core. The thermochromic core can include one or both of an organic thermochromic material and an inorganic salt thermochromic material. In some aspects, the particles include a dye selected from a crystal violet lactone dye, a fluoran dye, and a combination thereof. In still further aspects, the particles include a color developer selected from a hydroxybenzoate, a 4, 4′-dihydroxydiphenyl propane, a hydroxycoumarin derivative, a lauryl gallate, and a combination thereof. In some aspects, the metal oxide shell is a TiO.sub.2 shell. The particles can be used in cements and paints and for a variety of building materials. Methods of making the particles and building materials and methods of use, for example, for removing a volatile organic carbon from a building material, are also provided.

A variety of particles forming microencapsulated thermochromic materials are provided. The particles can include a thermochromic core and a metal oxide shell encapsulating the thermochromic core. The thermochromic core can include one or both of an organic thermochromic material and an inorganic salt thermochromic material. In some aspects, the particles include a dye selected from a crystal violet lactone dye, a fluoran dye, and a combination thereof. In still further aspects, the particles include a color developer selected from a hydroxybenzoate, a 4, 4′-dihydroxydiphenyl propane, a hydroxycoumarin derivative, a lauryl gallate, and a combination thereof. In some aspects, the metal oxide shell is a TiO.sub.2 shell. The particles can be used in cements and paints and for a variety of building materials. Methods of making the particles and building materials and methods of use, for example, for removing a volatile organic carbon from a building material, are also provided.

The present disclosure relates to a microfluidic chip and a control method thereof, a droplet generation device and a microsphere preparation device. The microfluidic chip includes a matrix (3), and a first flow channel (1) and a second flow channel (2) provided in the matrix (3), wherein the first flow channel (1) and the second flow channel (2) intersect to form an intersection area, sheared phase fluid can flow in from the first flow channel (1), shearing phase fluid can flow in from the second flow channel (2) so as to separate the sheared phase fluid into discrete droplets in the intersection area, and the cross-sectional areas of the first flow channel (1) and the second flow channel (2) range from 0.1 mm.sup.2 to 1 mm.sup.2. The microfluidic chip can increase the flow rate and improve the efficiency of forming droplets; and the efficiency of generating the droplets is increased on the basis of ensuring the cell activity in order to meet the requirements of 3D biological printing.

The present disclosure relates to a microfluidic chip and a control method thereof, a droplet generation device and a microsphere preparation device. The microfluidic chip includes a matrix (3), and a first flow channel (1) and a second flow channel (2) provided in the matrix (3), wherein the first flow channel (1) and the second flow channel (2) intersect to form an intersection area, sheared phase fluid can flow in from the first flow channel (1), shearing phase fluid can flow in from the second flow channel (2) so as to separate the sheared phase fluid into discrete droplets in the intersection area, and the cross-sectional areas of the first flow channel (1) and the second flow channel (2) range from 0.1 mm.sup.2 to 1 mm.sup.2. The microfluidic chip can increase the flow rate and improve the efficiency of forming droplets; and the efficiency of generating the droplets is increased on the basis of ensuring the cell activity in order to meet the requirements of 3D biological printing.

The present invention relates to hydrogel beads having liquid crystalline structured phase. Process for preparing crystalline hydrogel beads is also an object of the invention. Perfuming compositions and consumer products comprising or consisting of said crystalline beads, in particular perfumed consumer products in the form of a personal care products or flavoured products, are also part of the invention.

The present invention relates to hydrogel beads having liquid crystalline structured phase. Process for preparing crystalline hydrogel beads is also an object of the invention. Perfuming compositions and consumer products comprising or consisting of said crystalline beads, in particular perfumed consumer products in the form of a personal care products or flavoured products, are also part of the invention.

The present invention relates to a magnetic-optical composite nanostructure, which has a heterogeneous nature due to consisting of a first core-shell nanoparticle and second core-shell nanoparticles and thus realizes magnetic and optical functions at the same time.

A composition having one or more leak resistant capsules.

Water-soluble unit dose articles that include a water-soluble fibrous non-woven substrate and a particulate treatment composition, the composition including capsules, where the capsules have a shell that includes inorganic material. Related methods of treating a fabric.

In a method for manufacturing core-shell particles including core particles and a shell, the constituent metal elements of the core particles and the shell are different from each other. A quinone-containing core particle dispersion containing at least core particles consisting of a first metal, hydroquinone (HQ), benzoquinone (BQ), and a second metal compound including a second metal element for making up the shell is prepared, and a reduction treatment is performed on the quinone-containing core particle dispersion, through addition of a reducing agent, to form a shell including the second metal element as a main constituent element, on the surface of the core particles. A mass ratio: HQ/BQ ratio of added hydroquinone (HQ) and benzoquinone (BQ) is 0.1 to 120.